Literature DB >> 3186623

Pharmacokinetics of 7-hydroxy-methotrexate and methotrexate in the rat.

L Slørdal1, R Jaeger, J Kjaeve, J Aarbakke.   

Abstract

To investigate the pharmacokinetics of the active metabolite of methotrexate (MTX), 7-hydroxy-methotrexate (7-OH-MTX), 1 mg/kg of the compound was administered as single intravenous bolus injections to 6 unanaesthetized rats. For comparison, 1 mg/kg of the parent drug MTX was given to the same number of animals. Venous blood samples were drawn at intervals for a total of 120 min., and thereafter the rats were sacrificed and tissue samples were obtained from the brain, lungs, liver, kidneys, testes, fat, and muscle. Pharmacokinetics of 7-OH-MTX and MTX were biphasic, with a significantly (P less than 0.05) smaller central compartment of distribution (Vc) and a longer second phase half-life (t1/2(beta)) for 7-OH-MTX. MTX tissue concentrations exceeded those of 7-OH-MTX in all tissues examined. The highest 7-OH-MTX concentrations were found in renal tissue. It is implied that 7-OH-MTX is less extensively distributed than the parent compound.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3186623     DOI: 10.1111/j.1600-0773.1988.tb00915.x

Source DB:  PubMed          Journal:  Pharmacol Toxicol        ISSN: 0901-9928


  5 in total

1.  Pharmacokinetics of methotrexate in the extracellular fluid of brain C6-glioma after intravenous infusion in rats.

Authors:  S Dukic; T Heurtaux; M L Kaltenbach; G Hoizey; A Lallemand; B Gourdier; R Vistelle
Journal:  Pharm Res       Date:  1999-08       Impact factor: 4.200

2.  Evaluation of methotrexate tissue exposure by in situ microdialysis in a rat model.

Authors:  O Ekstrøm; A Andersen; D J Warren; K E Giercksky; L Slørdal
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

3.  Renal and hepatic toxicity after high-dose 7-hydroxymethotrexate in the rat.

Authors:  E Smeland; R M Bremnes; A Andersen; R Jaeger; T J Eide; N E Huseby; J Aarbakke
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

Review 4.  Recent progress towards development of effective systemic chemotherapy for the treatment of malignant brain tumors.

Authors:  Hemant Sarin
Journal:  J Transl Med       Date:  2009-09-01       Impact factor: 5.531

Review 5.  Examination of Urinary Excretion of Unchanged Drug in Humans and Preclinical Animal Models: Increasing the Predictability of Poor Metabolism in Humans.

Authors:  Nadia O Bamfo; Chelsea Hosey-Cojocari; Leslie Z Benet; Connie M Remsberg
Journal:  Pharm Res       Date:  2021-07-12       Impact factor: 4.580

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.